|
| 36647675 | Correction: Macrophage Exclusion after Radiation Therapy (MERT): A First-in-Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma. | Clin Cancer Res | 2023 |
| 33243481 | In Regard to Song et al. | Int J Radiat Oncol Biol Phys | 2021 |
| 33864825 | In Reply to Song et al, and In Reply to Brown and Carlson. | Int J Radiat Oncol Biol Phys | 2021 |
| 33610292 | In Regard to Nam et al. | Int J Radiat Oncol Biol Phys | 2021 |
| 34793735 | Reflections of the Senior Editors for Biology. | Int J Radiat Oncol Biol Phys | 2021 |
| 32473180 | Radiation Damage to Tumor Vasculature Initiates a Program That Promotes Tumor Recurrences. | Int J Radiat Oncol Biol Phys | 2020 |
| 31812931 | Macrophage exclusion after radiation therapy (MERT): A new and effective way to increase the therapeutic ratio of radiotherapy. | Radiother Oncol | 2020 |
| 30529372 | Beware of Clinical Trials of DNA Repair Inhibitors. | Int J Radiat Oncol Biol Phys | 2019 |
| 31537527 | Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma. | Clin Cancer Res | 2019 |
| 31040924 | Dynamin 2, cell trafficking, and the triple-negative paradox. | Oncotarget | 2019 |
| 29726389 | Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. | Lancet Oncol | 2018 |
| 29859786 | <sup>18</sup>F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2018 |
| 29976509 | The Biology of SBRT: LQ or Something New? | Int J Radiat Oncol Biol Phys | 2018 |
| 30371505 | Dynamin impacts homology-directed repair and breast cancer response to chemotherapy. | J Clin Invest | 2018 |
| 28341752 | The Promise of Targeting Macrophages in Cancer Therapy. | Clin Cancer Res | 2017 |
| 26947881 | Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations. | Transl Oncol | 2016 |
| 26538619 | Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization. | Neuro Oncol | 2016 |
| 27154913 | Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials. | Clin Cancer Res | 2016 |
| 26058991 | High-dose and fractionation effects in stereotactic radiation therapy: Analysis of tumor control data from 2965 patients. | Radiother Oncol | 2015 |
| 26530765 | In Reply to Rudoltz and Goldwein et al. | Int J Radiat Oncol Biol Phys | 2015 |
| 26286478 | Cell Death Identification in Anticancer Therapy-Letter. | Cancer Res | 2015 |
| 26104924 | Is Equipment Development Stifling Innovation in Radiation Oncology? | Int J Radiat Oncol Biol Phys | 2015 |
| 26068491 | Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2015 |
| 24497508 | Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8. | Proc Natl Acad Sci U S A | 2014 |
| 25047738 | Circulating mouse Flk1+/c-Kit+/CD45- cells function as endothelial progenitors cells (EPCs) and stimulate the growth of human tumor xenografts. | Mol Cancer | 2014 |
| 24929172 | Dose escalation, not â¿¿new biology,â¿ can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In reply to Rao et al. | Int J Radiat Oncol Biol Phys | 2014 |
| 24338942 | Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy. | Br J Radiol | 2014 |
| 24335554 | Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats. | Neuro Oncol | 2014 |
| 24423923 | Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats. | Br J Cancer | 2014 |
| 24411596 | The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? | Int J Radiat Oncol Biol Phys | 2014 |
| 23517805 | Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. | Int J Radiat Oncol Biol Phys | 2013 |
| 23882218 | The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery. | Front Physiol | 2013 |
| 22354749 | Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. | Cancer Res | 2012 |
| 22825248 | R-loops and genomic instability in Bre1 (RNF20/40)-deficient cells. | Cell Cycle | 2012 |
| 22317761 | Imaging tumor sensitivity to a bioreductive prodrug: two for the price of one! | Clin Cancer Res | 2012 |
| 22336907 | Inhibiting homologous recombination for cancer therapy. | Cancer Biol Ther | 2012 |
| 21183291 | Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia. | Int J Radiat Oncol Biol Phys | 2011 |
| 21867428 | Radiation Resistance in Cancer Therapy: meeting summary and research opportunities. Report of an NCI Workshop held September 1-3, 2010. | Radiat Res | 2011 |
| 21587260 | Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas. | Br J Cancer | 2011 |
| 21740251 | Radiation Resistance in Cancer Therapy: Meeting Summary and Research Opportunities: Report of an NCI Workshop held September 1-3, 2010. | Radiat Res | 2011 |
| 21646472 | Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1. | Cancer Res | 2011 |
| 20404138 | Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. | Proc Natl Acad Sci U S A | 2010 |
| 20732963 | Pharmacokinetic/pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors. | Clin Cancer Res | 2010 |
| 20832663 | Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. | Int J Radiat Oncol Biol Phys | 2010 |
| 20738173 | Deficiency in Bre1 impairs homologous recombination repair and cell cycle checkpoint response to radiation damage in mammalian cells. | Radiat Res | 2010 |
| 20179352 | Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. | J Clin Invest | 2010 |
| 20167863 | Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. | Am J Pathol | 2010 |
| 19221886 | Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature. | Angiogenesis | 2009 |
| 19366798 | DNA cross-links in human tumor cells exposed to the prodrug PR-104A: relationships to hypoxia, bioreductive metabolism, and cytotoxicity. | Cancer Res | 2009 |
| 19509245 | Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated dinitrobenzamide mustard PR-104A. | Mol Cancer Ther | 2009 |